Ares Financial Consulting’s Medline Inc MDLN Stock Holding History

Ares Financial Consulting’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1K	Buy	+28	New	+$1.13K	﹤0.01%	992

Other funds holding MDLN

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ECU

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Ares Financial Consulting's MDLN Position: Q2 2026 in Review

Ares Financial Consulting opened a new position in Medline Inc (MDLN) in Q2 2026: 28 shares worth $1.1K. The stake represents ﹤0.01% of the portfolio and ranks #992 among its holdings.

137 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Ares Financial Consulting held 28 shares of Medline Inc worth $1.1K as of Q2 2026.
Medline Inc was a new Ares Financial Consulting position in Q2 2026.
Medline Inc made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #992 holding.
137 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.